![Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group - The Lancet Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group - The Lancet](https://www.thelancet.com/cms/attachment/2052247457/2059676798/gr1.gif)
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group - The Lancet
![Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-020-07186-5/MediaObjects/12885_2020_7186_Fig1_HTML.png)
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer
![Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-020-07186-5/MediaObjects/12885_2020_7186_Fig4_HTML.png)
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer
![Establishing Synoptic Cancer Pathology Reporting in Low- and Middle-Income Countries: A Nicaraguan Experience | JCO Global Oncology Establishing Synoptic Cancer Pathology Reporting in Low- and Middle-Income Countries: A Nicaraguan Experience | JCO Global Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/go/2022/go.2022.8/jgo.19.00343/20220209/images/large/jgo.19.00343t4.jpeg)
Establishing Synoptic Cancer Pathology Reporting in Low- and Middle-Income Countries: A Nicaraguan Experience | JCO Global Oncology
Protocol for the Examination of Resection Specimens From Patients With Primary Carcinoma of the Colon and Rectum
![Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-0116-z/MediaObjects/41392_2020_116_Fig1_HTML.png)
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Diseases of the Colon & Rectum - Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol NRG Oncology/NSABP R-04 - the latest #DCRJournal #ColorectalCancer
![Fragment of CAP cancer checklist and ADASP guidelines for reporting... | Download Scientific Diagram Fragment of CAP cancer checklist and ADASP guidelines for reporting... | Download Scientific Diagram](https://www.researchgate.net/publication/5454262/figure/fig7/AS:295137176506384@1447377594737/Fragment-of-CAP-cancer-checklist-and-ADASP-guidelines-for-reporting-mesothelioma.png)
Fragment of CAP cancer checklist and ADASP guidelines for reporting... | Download Scientific Diagram
The Oncologist's Guide to Synoptic Reporting: A Primer - FullText - Oncology 2020, Vol. 98, No. 6 - Karger Publishers
![Frontiers | Proof-of-Concept Pilot Study on Comprehensive Spatiotemporal Intra-Patient Heterogeneity for Colorectal Cancer With Liver Metastasis Frontiers | Proof-of-Concept Pilot Study on Comprehensive Spatiotemporal Intra-Patient Heterogeneity for Colorectal Cancer With Liver Metastasis](https://www.frontiersin.org/files/MyHome%20Article%20Library/855463/855463_Thumb_400.jpg)